Taipei Exchange - Delayed Quote TWD

Pharmosa Biopharm Inc. (6875.TWO)

47.90
-1.15
(-2.34%)
At close: 1:30:39 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
167,493
167,568
314,500
0
--
Cost of Revenue
40,600
40,665
0
--
--
Gross Profit
126,893
126,903
314,500
--
--
Operating Expense
386,368
345,470
317,324
271,533
259,120
Operating Income
-259,475
-218,567
-2,824
-271,533
-259,120
Net Non Operating Interest Income Expense
33,293
29,655
6,668
-149
-1,114
Pretax Income
-206,656
-166,653
8,456
-266,506
-256,479
Tax Provision
--
0
0
0
--
Net Income Common Stockholders
-206,656
-166,653
8,456
-266,506
-256,479
Diluted NI Available to Com Stockholders
-206,656
-166,653
8,456
-266,506
-256,479
Basic EPS
-1.59
-1.32
0.07
-2.70
-2.95
Diluted EPS
-1.59
-1.32
0.07
-2.70
-2.95
Basic Average Shares
129,289.93
126,425
113,221
100,741
87,136.67
Diluted Average Shares
129,289.93
126,425
113,393
100,741
87,136.67
Total Expenses
426,968
386,135
317,324
271,533
259,120
Net Income from Continuing & Discontinued Operation
-206,656
-166,653
8,456
-266,506
-256,479
Normalized Income
-206,656
-166,653
8,456
-266,506
-256,479
Interest Income
35,628
32,074
9,525
500
100
Interest Expense
2,335
2,419
2,857
649
1,214
Net Interest Income
33,293
29,655
6,668
-149
-1,114
EBIT
-204,321
-164,234
11,313
-265,857
-255,265
EBITDA
-176,918
-138,429
34,634
-253,157
-243,465
Reconciled Cost of Revenue
40,600
40,665
0
--
--
Reconciled Depreciation
27,403
25,805
23,321
12,700
11,800
Net Income from Continuing Operation Net Minority Interest
-206,656
-166,653
8,456
-266,506
-256,479
Normalized EBITDA
-176,918
-138,429
34,634
-253,157
-243,465
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/22/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers